Location: Home
  • search
  • go
  • Relate News
  • 2/28/2017Financial-related Company News in Brief (01-02/2017)
  • 2/28/2017Good Times Ahead for Chinese Pharmaceutical Firms as Policy Environmen...
  • 2/28/2017Modular Bioprocess Facilities Expanding Capacity in China
  • 2/28/2017WuXi AppTec's Shanghai Bioanalytical Facility Passed FDA Inspection
  • 2/28/2017Upcoming Event: Pharma China Annual Forum 2017 in Shanghai on April 14
  • 2/28/2017Upcoming Event: Negotiation with International Healthcare Companies - ...
  • 2/28/2017CDE Publicizes List of Drug Applications To Be Granted Priority Review...
  • 2/28/2017China Approves Boehringer Ingelheim’s Giotrif (Afatinib)
  • 2/28/2017China's New Two-Invoice System in Pharma Distribution Aims to Reduce D...
  • 2/28/2017CNMG Awarded $2.29M Grant from CIRM to Fund AlloJoin Allogeneic Stem C...
  • 2/28/2017Xynomic Pharma Acquires Worldwide Rights of Anticancer Candidate Abexi...
  • 2/27/2017Nicholas Hall Reports 8% Growth of OTC Gastrointestinal Market in Chin...
  • 2/27/2017CFDA Minister Highlights Direction of Drug Evaluation and Approval Sys...
  • 2/26/2017CFDA Accepts NDA of Ascletis’s Novel HCV Drug Denoprevir
  • 2/23/2017Recent Executive Moves
  • 2/23/2017U.S. and China Asthma and COPD Drugs Markets Poised for Steady Growth
  • 2/23/2017Solidiance's Latest White Paper: China's Healthcare Reforms, Who Will ...
  • 2/23/2017FibroGen's Roxadustat (FG-4592) Meets Primary Endpoints in Two Phase 3...
  • 2/23/2017CFDA Solicits Comments for Draft Drug Registration Related Announcemen...
  • 2/23/2017MOHRSS Issues the 2017 Edition of NRDL with 339 Additions
  • 2/22/2017WHO: 100 Mln People in China Have Hepatitis B or C
  • 2/22/2017Adgero Gets $2M Investment from Fudan-Zhangjiang Biopharma
  • 2/22/2017Global Pharmerging Market to Grow at a CAGR of 12.88% in Spending to S...
  • 2/22/2017CFDA Issues Notice for Pharmaceutical Technology Transfer Related Matt...
  • 2/22/2017CFDA Issues Announcement over Import and Custom Clearance of Pharma Ex...
  • 2/22/20172017 Spring Promotion for Pharma China Publications
  • 2/21/2017Despite Strong Albumin Sales, CSL Complains of Barriers in China Busin...
  • 2/21/2017Eisai Acquires China Rights of PD Drugs from Orion Corp.
  • 2/21/2017Neovacs Outlicenses China Rights of IFNα Kinoid Vaccine to BioSense
  • 2/21/2017Updated: China Issues 13th FYP for National Drug Safety
  • Page:386/789 Total number of articles:23668: [First][<<] [384] [385] [386] [387] [388] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group